Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00365157
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-12
First Post:
2006-08-16
Brief Title:
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unresectable Urothelial Carcinoma |
| Advanced Urothelial Carcinoma |
| Locally Advanced Urothelial Carcinoma |
| Metastatic Urothelial Carcinoma |
| Recurrent Urothelial Carcinoma |
| Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 |
| Stage IV Bladder Urothelial Carcinoma AJCC v7 |
Keywords: